Loteate Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid used for the treatment of inflammatory conditions of the eye. It is indicated for the management of ocular inflammation and pain associated with allergic conjunctivitis, postoperative inflammation following ocular surgery, and other steroid-responsive inflammatory conditions of the anterior segment of the eye. Loteprednol etabonate is a soft steroid designed to provide potent anti-inflammatory effects with a reduced risk of steroid-related side effects such as elevated intraocular pressure. The mechanism of action involves inhibition of the release of inflammatory mediators and suppression of the immune response, thereby reducing redness, swelling, and discomfort. Loteate Eye Drop should be used as directed by a healthcare professional, typically administered as one to two drops in the affected eye(s) two to four times daily, with dosage adjustments based on clinical response. Caution is advised in patients with ocular infections, glaucoma, or a history of steroid-induced ocular hypertension. Prolonged use may increase the risk of cataract formation and secondary infections. Patients should avoid contact lens use during treatment unless otherwise directed. Proper hygiene and adherence to prescribed dosing are essential to minimize adverse effects and ensure therapeutic efficacy.